Pinpointing Recurrent Genomic Alterations in Breast Cancer
A genomic analysis study by Rutgers Cancer Institute of New Jersey investigators and others has identified recurrent genomic alterations in a subset of breast cancer that are typically associated with a form of thyroid cancer and an intestinal birth defect. Associate Director for Translational Science and Omar Boraie Chair in Genomic Science Shridar Ganesan, MD, PhD, and breast medical oncologist Kim M. Hirshfield, MD, PhD, who are both faculty members at Rutgers Robert Wood Johnson Medical School, were involved in the work that was presented at the recent San Antonio Breast Cancer Symposium.